Anti‐proliferative and anti‐migratory effects of hyperforin in 2D and 3D artificial constructs of human dermal fibroblasts – A new option for hypertrophic scar treatment?

Graphical abstract Figure. No Caption available. ABSTRACT Hyperforin (HYP), one of the main bioactive compounds in extracts of Hypericum perforatum, is a potential drug candidate for the treatment of skin diseases. Since extracts have proven to support wound healing, in the present study effects of HYP on human dermal fibroblasts (HDF) were evaluated in 2D and 3D in vitro dermal constructs. Viability and cytotoxicity assays as well as a live‐dead cell staining were performed to test at which concentration HYP reduces viability and/or shows cytotoxicity. Furthermore a differentiation between cytotoxic, anti‐proliferative and anti‐migratory effects was done. For the latter purpose a 2D migration assay was performed. HDF‐induced contraction of a 3D artificial dermal (AD) construct was determined at given HYP concentration. Induction of apoptosis was examined by determination of caspase 3/7 activities. HYP reduced viability of HDF down to 70% at concentrations of 5–10 &mgr;M. This decrease was not due to cytotoxicity but to a reduction in proliferation as shown from both the proliferation assay and the cytotoxicity assay as well as from live‐dead cell staining. The 2D migration assay showed that HYP reduced migration activity of HDF cells at a concentration of 10 &mgr;M. At this concentration HYP also reduced the HDF‐induced contraction of collagen gels as 3D AD constructs. Apoptotic effects of HYP were excluded performing a caspase 3/7 activity detecting assay. The results show for the first time that HYP may be rather a potential candidate for treatment of hypertrophic scars than promoting effects which are understood as important in wound healing.

[1]  B. Hinz,et al.  Dissecting the roles of endothelin,TGF-β and GM-CSF on myofibroblast differentiation by keratinocytes , 2004, Thrombosis and Haemostasis.

[2]  G. Brahmachari.  Hyperforin , 2019, Total Synthesis of Bioactive Natural Products.

[3]  Bruce Blumberg,et al.  Hyperforin, the Active Component of St. John’s Wort, Induces IL-8 Expression in Human Intestinal Epithelial Cells Via a MAPK-Dependent, NF-κB-Independent Pathway , 2004, Journal of Clinical Immunology.

[4]  Sabine Schanzer,et al.  In vivo photoprotective and anti-inflammatory effect of hyperforin is associated with high antioxidant activity in vitro and ex vivo. , 2012, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[5]  M. Medina,et al.  Hyperforin: more than an antidepressant bioactive compound? , 2006, Life sciences.

[6]  M Kieser,et al.  St. John's wort in mild to moderate depression: the relevance of hyperforin for the clinical efficacy. , 1998, Pharmacopsychiatry.

[7]  H. Ehrlich,et al.  Cell locomotion forces versus cell contraction forces for collagen lattice contraction: an in vitro model of wound contraction. , 1990, Tissue & cell.

[8]  P. Ngo,et al.  Collagen gel contraction assay. , 2006, Methods in molecular biology.

[9]  Walter E. Müller,et al.  Specific TRPC6 Channel Activation, a Novel Approach to Stimulate Keratinocyte Differentiation* , 2008, Journal of Biological Chemistry.

[10]  Terry J. Smith,et al.  Fibroblasts as sentinel cells. Synthesis of chemokines and regulation of inflammation. , 1997, The American journal of pathology.

[11]  R. Benner,et al.  Expression of cytokines and their receptors by psoriatic fibroblast. I. Altered IL-6 synthesis. , 1996, Cytokine.

[12]  E Glowacka,et al.  IL-8, IL-12 and IL-10 cytokines generation by neutrophils, fibroblasts and neutrophils- fibroblasts interaction in psoriasis. , 2010, Advances in medical sciences.

[13]  M. Bornstein.  Reconstituted rattail collagen used as substrate for tissue cultures on coverslips in Maximow slides and roller tubes. , 1958, Laboratory investigation; a journal of technical methods and pathology.

[14]  G. G. Stokes.  "J." , 1890, The New Yale Book of Quotations.

[15]  Michael Heinrich,et al.  Antibacterial activity of hyperforin from St John's wort , 1999, The Lancet.

[16]  E Bell,et al.  Production of a tissue-like structure by contraction of collagen lattices by human fibroblasts of different proliferative potential in vitro. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[17]  Talat Khadivzadeh,et al.  The effect of Hypericum perforatum on the wound healing and scar of cesarean. , 2010, Journal of alternative and complementary medicine.

[18]  M C Meinke,et al.  Enhancement of skin radical scavenging activity and stratum corneum lipids after the application of a hyperforin-rich cream. , 2014, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[19]  M. Jordana,et al.  Immune-inflammatory functions of fibroblasts. , 1994, The European respiratory journal.

[20]  R. Lüdtke,et al.  Topical application of St John’s wort (Hypericum perforatum L.) and of its metabolite hyperforin inhibits the allostimulatory capacity of epidermal cells , 2000, The British journal of dermatology.

[21]  Sabine Werner,et al.  Keratinocyte-fibroblast interactions in wound healing. , 2007, The Journal of investigative dermatology.

[22]  A. Sava,et al.  Evaluation of the wound-healing effect of a novel Hypericum perforatum ointment in skin injury. , 2013, Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie.

[23]  J. Simon,et al.  Antibacterial activity of hyperforin from St John's wort, against multiresistant Staphylococcus aureus and gram-positive bacteria , 1999, The Lancet.

[24]  Yusuf Öztürk,et al.  Evaluation of the Wound Healing Potentials of Some Hypericum perforatum Subspecies on Cultured NIH3T3 Fibroblasts , 2011 .

[25]  T. Tuan,et al.  The molecular basis of keloid and hypertrophic scar formation. , 1998, Molecular medicine today.

[26]  A. Tanoue,et al.  Hyperforin inhibits cell proliferation and differentiation in mouse embryonic stem cells , 2013, Cell proliferation.

[27]  L. Beerhues,et al.  Molecules of InterestHyperforin , 2006 .

[28]  Christoph M Schempp,et al.  Topical Application of St. Johnʼs Wort (Hypericum perforatum) , 2013, Planta Medica.

[29]  F. Grinnell,et al.  Contraction of hydrated collagen gels by fibroblasts: evidence for two mechanisms by which collagen fibrils are stabilized. , 1987, Collagen and related research.

[30]  T. Mosmann.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.

[31]  Oliver Werz,et al.  Hyperforin is a dual inhibitor of cyclooxygenase-1 and 5-lipoxygenase. , 2002, Biochemical pharmacology.

[32]  Bornstein Mb,et al.  Reconstituted rattail collagen used as substrate for tissue cultures on coverslips in Maximow slides and roller tubes. , 1958, Laboratory investigation; a journal of technical methods and pathology.

[33]  W A Buurman,et al.  Expression of cytokines and their receptors by psoriatic fibroblasts. II. decreased TNF receptor expression. , 1996, Cytokine.

[34]  Wolf-Henning Boehncke,et al.  Reduced TRPC Channel Expression in Psoriatic Keratinocytes Is Associated with Impaired Differentiation and Enhanced Proliferation , 2011, PloS one.

[35]  Yusuf Öztürk,et al.  Evaluation of the wound healing potentials of two subspecies of Hypericum perforatum on cultured NIH3T3 fibroblasts , 2010 .

[36]  C. Müller-Goymann,et al.  Comparative investigations to evaluate the use of organotypic cultures of transformed and native dermal and epidermal cells for permeation studies. , 1998, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[37]  K. Kohn,et al.  Induction of a common pathway of apoptosis by staurosporine. , 1994, Experimental cell research.

[38]  C. Liang,et al.  In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro , 2007, Nature Protocols.